1. Are you saying that improved diagnosis is of no use in itself? In response to the COBRA diagnosis results previously announced, clinicians have already said that they will be changing treatment in half the patients IIRC.
2. CU6's targeting agent for therapy is identical to the targeting agent for diagnosis. Only the warhead differs.
- Forums
- ASX - By Stock
- CU6
- Ann: Additional COBRA trial data results
Ann: Additional COBRA trial data results, page-8
-
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CU6 (ASX) to my watchlist
|
|||||
Last
$5.42 |
Change
0.350(6.90%) |
Mkt cap ! $1.689B |
Open | High | Low | Value | Volume |
$5.10 | $5.53 | $5.10 | $8.270M | 1.560M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1951 | $5.40 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.44 | 4280 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 1951 | 5.400 |
1 | 1000 | 5.380 |
1 | 13671 | 5.350 |
1 | 187 | 5.310 |
1 | 1000 | 5.300 |
Price($) | Vol. | No. |
---|---|---|
5.500 | 2096 | 1 |
5.600 | 5550 | 2 |
5.610 | 500 | 1 |
5.620 | 500 | 1 |
5.700 | 946 | 1 |
Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
Featured News
CU6 (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
SPONSORED BY The Market Online